Monthly Archives: January 2016

ALKS 5461 Hits an Iceberg, The Boston Pops Plays On

Not wanting to be left out of the early-2016 chaos, the neuroscience area chimed in today with the announcement that Alkermes’ first two Phase III trials of ALKS 5461 had failed in Major Depression. In one trial (FORWARD-4), the higher … Continue reading

Posted in Biotech | Tagged , , | 1 Comment

Anything But Static: The Coming Era of Massive Paradigm Shifts

One of NIR’s favorite concepts–and one that almost invariably finds its way into our conference presentations and Innovation Reviews–is that of Treatment Paradigm Shifts. A TPS is a tangible and meaningful addition to the repertoire of what is available for … Continue reading

Posted in Big Pharma, Biotech, Science | Leave a comment